Open AccessEfficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer
Author(s) -
Kenan Zhou,
Shuhong Zhao,
Wenlai Guo,
Lei Ding
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000018771
Subject(s) - erlotinib , medicine , bevacizumab , oncology , lung cancer , adverse effect , meta analysis , randomized controlled trial , erlotinib hydrochloride , epidermal growth factor receptor , chemotherapy , cancer